Technical Analysis for XYNO - Xynomic Pharmaceuticals Holdings Inc.

Grade Last Price % Change Price Change
grade D 2.85 0.00% 0.0000
XYNO closed unchanged on Wednesday, January 22, 2020, on 13 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical XYNO trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Narrow Range Bar Range Contraction 16.33%
Older signals for XYNO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Xynomic Pharmaceuticals Holdings, Inc. a biopharmaceutical company, focuses on in-licensing, developing, and commercializing oncology drug candidates in China, the United States, and internationally. The company's pipeline primarily consists of three drug candidates, abexinostat, XP-105, and XP-102. Its lead drug candidate abexinostat is in pivotal clinical trials against renal cell carcinoma (in combination with pazopanib) and non-Hodgkin's lymphoma (as a single agent). The company's other clinical stage drug candidate XP-105 (BI 860585) is a Phase 2 ready, ATP-competitive mTORC1/2 inhibitor against solid tumors; and pre-clinical oncology drug candidate XP-102 (BI 882370) is a pan-RAF inhibitor. The company was founded in 2016 and is headquartered in Shanghai, China.
Biopharmaceutical Chemical Compounds Organic Compounds Solid Tumors Lymphoma Xp Renal Cell Carcinoma Pyrimidines Sulfonamides Indazoles Pazopanib Xp 102

Is XYNO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 5.28
52 Week Low 1.06
Average Volume 2,231
200-Day Moving Average 0.0000
50-Day Moving Average 3.4602
20-Day Moving Average 3.2520
10-Day Moving Average 3.0750
Average True Range 0.4298
ADX 34.11
+DI 22.8454
-DI 36.4090
Chandelier Exit (Long, 3 ATRs ) 2.8606
Chandelier Exit (Short, 3 ATRs ) 3.3995
Upper Bollinger Band 4.1699
Lower Bollinger Band 2.3341
Percent B (%b) 0.28
BandWidth 56.4514
MACD Line -0.2206
MACD Signal Line -0.1508
MACD Histogram -0.0698
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.8500
Resistance 3 (R3) 2.8500 2.8500 2.8500
Resistance 2 (R2) 2.8500 2.8500 2.8500 2.8500
Resistance 1 (R1) 2.8500 2.8500 2.8500 2.8500 2.8500
Pivot Point 2.8500 2.8500 2.8500 2.8500 2.8500
Support 1 (S1) 2.8500 2.8500 2.8500 2.8500 2.8500
Support 2 (S2) 2.8500 2.8500 2.8500 2.8500
Support 3 (S3) 2.8500 2.8500 2.8500
Support 4 (S4) 2.8500